BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 18439753)

  • 41. LncRNA-mir3471-limd1 regulatory network plays critical roles in HIBD.
    Sun L; Wan J; Sun B; Tian Q; Li M; Xu LX; Feng CX; Tong X; Feng X; Yang X; Ding X
    Exp Brain Res; 2024 Feb; 242(2):443-449. PubMed ID: 38147087
    [TBL] [Abstract][Full Text] [Related]  

  • 42. METTL8 mRNA Methyltransferase Enhances Cancer Cell Migration via Direct Binding to ARID1A.
    Lee SA; Lee KH; Kim H; Cho JY
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34063990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LIM domain proteins in cell mechanobiology.
    Anderson CA; Kovar DR; Gardel ML; Winkelman JD
    Cytoskeleton (Hoboken); 2021 Jun; 78(6):303-311. PubMed ID: 34028199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Algorithm-Based Meta-Analysis Reveals the Mechanistic Interaction of the Tumor Suppressor LIMD1 With Non-Small-Cell Lung Carcinoma.
    Wang L; Sparks-Wallace A; Casteel JL; Howell MEA; Ning S
    Front Oncol; 2021; 11():632638. PubMed ID: 33869018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LIMD1 Increases the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin via the GADD45α/p38 MAPK Signaling Pathway.
    Zeng X; Wang H; He D; Jia W; Ma R
    Front Oncol; 2020; 10():969. PubMed ID: 32754438
    [No Abstract]   [Full Text] [Related]  

  • 46. Hsa_circ_0128846 promotes tumorigenesis of colorectal cancer by sponging hsa-miR-1184 and releasing AJUBA and inactivating Hippo/YAP signalling.
    Wang X; Chen Y; Liu W; Liu T; Sun D
    J Cell Mol Med; 2020 Sep; 24(17):9908-9924. PubMed ID: 32681581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topological features of integrin adhesion complexes revealed by multiplexed proximity biotinylation.
    Chastney MR; Lawless C; Humphries JD; Warwood S; Jones MC; Knight D; Jorgensen C; Humphries MJ
    J Cell Biol; 2020 Aug; 219(8):. PubMed ID: 32585685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LIMD1-AS1 suppressed non-small cell lung cancer progression through stabilizing LIMD1 mRNA via hnRNP U.
    Pan J; Tang Y; Liu S; Li L; Yu B; Lu Y; Wang Y
    Cancer Med; 2020 Jun; 9(11):3829-3839. PubMed ID: 32239804
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identifying Methylation Pattern and Genes Associated with Breast Cancer Subtypes.
    Chen L; Zeng T; Pan X; Zhang YH; Huang T; Cai YD
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TRIP6 functions as a potential oncogene and facilitated proliferation and metastasis of gastric cancer.
    Zhu L; Xu X; Tang Y; Zhu X
    Biologics; 2019; 13():101-110. PubMed ID: 31354238
    [No Abstract]   [Full Text] [Related]  

  • 51. Silencing of LIMD1 promotes proliferation and reverses cell adhesion-mediated drug resistance in non-Hodgkin's lymphoma.
    Tang J; Zhu L; Huang Y; Shi B; Zhang S; Gu L; Zhao J; Deng M; Zhu J; Xun H; Wang Y; Wang C
    Oncol Lett; 2019 Mar; 17(3):2993-3000. PubMed ID: 30854077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LIMD1 is a survival prognostic marker of gastric cancer and hinders tumor progression by suppressing activation of YAP1.
    Zhang D; Li S; Yu W; Chen C; Liu T; Sun Y; Zhao Z; Liu L
    Cancer Manag Res; 2018; 10():4349-4361. PubMed ID: 30349368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxia.
    Foxler DE; Bridge KS; Foster JG; Grevitt P; Curry S; Shah KM; Davidson KM; Nagano A; Gadaleta E; Rhys HI; Kennedy PT; Hermida MA; Chang TY; Shaw PE; Reynolds LE; McKay TR; Wang HW; Ribeiro PS; Plevin MJ; Lagos D; Lemoine NR; Rajan P; Graham TA; Chelala C; Hodivala-Dilke KM; Spendlove I; Sharp TV
    EMBO Mol Med; 2018 Aug; 10(8):. PubMed ID: 29930174
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LIMD1 is induced by and required for LMP1 signaling, and protects EBV-transformed cells from DNA damage-induced cell death.
    Wang L; Howell MEA; McPeak B; Riggs K; Kohne C; Yohanon JU; Foxler DE; Sharp TV; Moorman JP; Yao ZQ; Ning S
    Oncotarget; 2018 Jan; 9(5):6282-6297. PubMed ID: 29464072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene expression profiling identifies IRF4-associated molecular signatures in hematological malignancies.
    Wang L; Yao ZQ; Moorman JP; Xu Y; Ning S
    PLoS One; 2014; 9(9):e106788. PubMed ID: 25207815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of TRIP6-dependent nasopharyngeal cancer cell migration.
    Fei J; Li J; Shen S; Zhou W
    Tumour Biol; 2013 Aug; 34(4):2329-35. PubMed ID: 23576104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity.
    Foxler DE; Bridge KS; James V; Webb TM; Mee M; Wong SC; Feng Y; Constantin-Teodosiu D; Petursdottir TE; Bjornsson J; Ingvarsson S; Ratcliffe PJ; Longmore GD; Sharp TV
    Nat Cell Biol; 2012 Jan; 14(2):201-8. PubMed ID: 22286099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and characterization of a set of conserved and new regulators of cytoskeletal organization, cell morphology and migration.
    Bai SW; Herrera-Abreu MT; Rohn JL; Racine V; Tajadura V; Suryavanshi N; Bechtel S; Wiemann S; Baum B; Ridley AJ
    BMC Biol; 2011 Aug; 9():54. PubMed ID: 21834987
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PU.1 is a major transcriptional activator of the tumour suppressor gene LIMD1.
    Foxler DE; James V; Shelton SJ; Vallim TQ; Shaw PE; Sharp TV
    FEBS Lett; 2011 Apr; 585(7):1089-96. PubMed ID: 21402070
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell Adhesion and Transcriptional Activity - Defining the Role of the Novel Protooncogene LPP.
    Grunewald TG; Pasedag SM; Butt E
    Transl Oncol; 2009 Aug; 2(3):107-16. PubMed ID: 19701494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.